This observation is consistent with previous reports that effective concentration of interleukin to increase malignant potentials of cancer cells is higher than its serum level in mice [36, 37], and suggests that the direct effect of IL-1β on melanoma cells should be more obvious in the severe inflammatory condition. This evidence concerns the gene IL1B and melanoma.